Clinical Trial Update: Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome [Phase 3]

View source ↗

Summary

The Phase III randomized study of Lucinactant for meconium aspiration syndrome in full-term newborns was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meconium Aspiration Syndrome

Drugs mentioned

• Lucinactant (lucinactant)

Snippet

Sponsor: Windtree Therapeutics | Conditions: Meconium Aspiration | Phase 3 | Status: TERMINATED | Results posted: 2012-05-01